Obefazimod

Obefazimod
Identifiers
  • 8-chloro-N-[4-(trifluoromethoxy)phenyl]quinolin-2-amine
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
KEGG
ChEMBL
Chemical and physical data
FormulaC16H10ClF3N2O
Molar mass338.71 g·mol−1
3D model (JSmol)
  • C1=CC2=C(C(=C1)Cl)N=C(C=C2)NC3=CC=C(C=C3)OC(F)(F)F
  • InChI=1S/C16H10ClF3N2O/c17-13-3-1-2-10-4-9-14(22-15(10)13)21-11-5-7-12(8-6-11)23-16(18,19)20/h1-9H,(H,21,22)
  • Key:OZOGDCZJYVSUBR-UHFFFAOYSA-N

Obefazimod is an investigational new drug that is being evaluated for the treatment of ulcerative colitis.[1] It is miR-124 micro RNA upregulator.[2] Obefazimod was developed by the French biotech company Abivax SA, whose shares rose by more than 500% when the phase 3 data showed promising results.

References

  1. ^ "Obefazimod - Abivax". AdisInsight. Springer Nature Switzerland AG.
  2. ^ Datta N, Johnson C, Kao D, Gurnani P, Alexander C, Polytarchou C, et al. (August 2023). "MicroRNA-based therapeutics for inflammatory disorders of the microbiota-gut-brain axis". Pharmacological Research. 194 106870. doi:10.1016/j.phrs.2023.106870. PMID 37499702.


Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.